Johnson Fistel Investigates Simulations Plus Following Revenue Guidance Cut and Accounting Disclosures
Johnson Fistel, PLLP is investigating Simulations Plus, Inc. (NASDAQ: SLP) for investors who suffered losses following a significant revenue guidance cut, preliminary third-quarter revenue results, and subsequent decline in share value. Further concerns arose after a large net loss, a non-cash impairment charge, and the dismissal of their independent accounting firm, Grant Thornton LLP, which cited unresolved issues regarding segment reporting and internal controls. The firm is encouraging affected investors to contact them for more information regarding the investigation.
Rice Hall James & Associates LLC Purchases Shares of 103,010 Simulations Plus, Inc. $SLP
Rice Hall James & Associates LLC recently acquired 103,010 shares of Simulations Plus, Inc. (NASDAQ:SLP) worth approximately $1.89 million, representing 0.51% of the company. Institutional investors now own 78.08% of the stock. Despite the institutional interest, analysts maintain a "Reduce" rating for Simulations Plus, with an average price target of $17.25, even though the company recently surpassed quarterly earnings and revenue expectations.
Simulations Plus (NASDAQ:SLP): What Is Driving the Debate?
Simulations Plus (NASDAQ:SLP) is experiencing increased market caution despite stronger-than-expected quarterly results, highlighting a disconnect between operational performance and investor sentiment. The company, which specializes in pharmaceutical modeling and simulation software, benefits from growing demand for digital tools in drug development. Valuation concerns and future growth expectations are key factors contributing to the market's cautious stance, even as institutional activity shows continued interest in the stock.
Short Interest in Simulations Plus, Inc. (NASDAQ:SLP) Grows By 59.7%
Short interest in Simulations Plus, Inc. (NASDAQ:SLP) increased by 59.7% in July, reaching 2.84 million shares, which represents 17.4% of outstanding shares and a 5.2 days-to-cover ratio. This surge in short interest comes amidst weakening analyst sentiment, with several firms downgrading the stock to "Hold" or "Market Perform," resulting in a consensus "Reduce" rating and an average price target of $17.25. Despite this bearish trend, the company exceeded quarterly expectations with $0.30 EPS and $21.89 million in revenue.
Quantinno Capital Management LP Boosts Stock Holdings in Simulations Plus, Inc. $SLP
Quantinno Capital Management LP significantly increased its stake in Simulations Plus, Inc. (NASDAQ:SLP) by 439.1% in the first quarter, now holding 112,259 shares valued at $1.33 million. Despite this, analyst sentiment remains cautious with an average "Reduce" rating and a $17.25 price target, even though the company exceeded its recent quarterly earnings and revenue expectations. Institutional investors and hedge funds collectively own 78.08% of the company's stock.
Simulations Plus Announces Expiration of Hart-Scott-Rodino Waiting Period for Pending Acquisition by Altaris
Simulations Plus, Inc. announced the expiration of the Hart-Scott-Rodino (HSR) Antitrust Improvements Act waiting period, a key regulatory condition for its acquisition by Altaris, LLC. While this satisfies one major requirement, the acquisition is still contingent on shareholder approval, certain French regulatory approvals, and other customary closing conditions. The transaction is projected to close in the second half of calendar year 2026.
Simulations Plus HSR waiting period expires, Merger with Altaris remains subject to shareholder and French approvals
Simulations Plus announced that the Hart-Scott-Rodino waiting period for its merger with Altaris has expired, fulfilling a key regulatory condition. However, the merger still requires shareholder approval and certain French regulatory approvals. The transaction is anticipated to close in the second half of 2026, provided all remaining conditions are met or waived.
Simulations Plus (SLP) gains HSR clearance for pending Altaris acquisition
Simulations Plus (SLP) announced that it has received Hart-Scott-Rodino (HSR) antitrust clearance for its pending acquisition by Altaris affiliates. This satisfies one key regulatory condition for the merger, which is still subject to shareholder approval and certain regulatory approvals in France. The transaction is currently expected to close in the second half of calendar 2026.
Renaissance Technologies LLC Purchases 161,500 Shares of Simulations Plus, Inc. $SLP
Renaissance Technologies LLC significantly increased its stake in Simulations Plus, Inc. (NASDAQ:SLP) by purchasing 161,500 additional shares, bringing their total to 181,500 shares valued at $2.15 million. This move comes despite a cautious analyst sentiment, with several firms downgrading the stock to "Hold" or "Market Perform." Simulations Plus reported better-than-expected quarterly earnings and revenue, but insider Walter S. Woltosz also sold over 4,000 shares.
First Eagle Investment Management (SLP) reports 5.30% beneficial stake in Simulations Plus
First Eagle Investment Management, LLC has reported a beneficial ownership of 5.30% in Simulations Plus Inc., totaling 4,674,801.24 shares. The firm acts as an investment adviser for various clients, holding sole voting and dispositive power over 1,070,582 shares. This disclosure, filed under SCHEDULE 13G, indicates a passive investment primarily on behalf of its advisory clients.
Johnson Fistel Investigates Simulations Plus Following Revenue Guidance Cut and Accounting Disclosures
Johnson Fistel, PLLP is investigating Simulations Plus, Inc. (NASDAQ: SLP) after the company cut its fiscal 2025 revenue guidance and disclosed significant accounting issues. The investigation follows a substantial decline in Simulations Plus's share price after these announcements, including a $77.2 million non-cash impairment charge and the dismissal of its independent auditor. Investors who suffered losses are encouraged to contact Johnson Fistel to learn more.
Johnson Fistel Investigates Simulations Plus Following Revenue Guidance Cut and Accounting Disclosures
Johnson Fistel, PLLP is investigating Simulations Plus, Inc. (NASDAQ: SLP) after the company cut its fiscal 2025 revenue guidance and disclosed a significant non-cash impairment charge and the dismissal of its independent registered public accounting firm. The accounting firm, Grant Thornton LLP, subsequently informed the SEC of unresolved issues regarding segment reporting, reporting-unit determinations, and internal control over financial reporting. Investors who suffered losses are encouraged to contact Johnson Fistel for more information.
Simulations Plus, Inc. (NASDAQ:SLP) Receives Consensus Recommendation of "Reduce" from Analysts
Simulations Plus, Inc. (NASDAQ:SLP) has received a consensus "Reduce" rating from analysts, with an average 12-month price target of $17.25, below its opening price of $18.32. This comes despite the company exceeding quarterly earnings expectations with an EPS of $0.30 and revenue of $21.89 million. Institutional investors own a significant portion of the shares, while a director recently sold 4,177 shares under a pre-arranged trading plan.
Simulations Plus Chief Revenue Officer John Anthony DiBella II sells 1,000 shares for $18,280
Simulations Plus Chief Revenue Officer John Anthony DiBella II sold 1,000 common shares on August 3rd for $18.28 each, totaling $18,280. This transaction reduced his direct holdings to 85,140 shares. The information was generated using AI from a filing with the U.S. Securities and Exchange Commission.
Simulations Plus, Inc. (SLP) CRO sells 1,000 shares under Rule 10b5-1 plan
Simulations Plus, Inc.'s Chief Revenue Officer, John Anthony DiBella II, sold 1,000 shares of common stock on August 3, 2026, at $18.28 per share through a Rule 10b5-1 trading plan. Following this transaction, DiBella directly holds 85,140 shares. The sale was executed automatically and reported via a Form 4 filing.
Simulations Plus (SLP) insider schedules 3,000-share Rule 144 sale and details 10b5-1 trades
Simulations Plus (SLP) insider John Anthony DiBella II has filed a Rule 144 notice to sell 3,000 common shares, valued at $54,690, which originated from previously exercised options. The filing also details three separate 10b5-1 plan sales, each for 1,000 shares, that occurred in May, June, and July 2026, totaling over $49,000. These transactions provide transparency into insider stock divestment under specific regulatory frameworks.
Simulations Plus Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Simulations Plus, Inc. - SLP
Kahn Swick & Foti, LLC (KSF) is investigating the proposed sale of Simulations Plus, Inc. (NasdaqGS: SLP) to affiliates of Altaris, LLC for $18.50 per share in cash. KSF is seeking to determine if this consideration and the process leading to it are adequate, suspecting the company might be undervalued. Shareholders are invited to contact KSF to discuss their legal rights regarding the proposed transaction.
SLP|Simulations Plus Inc|Price:18.340|Chg%:+0.010
TradingKey provides a comprehensive stock analysis for Simulations Plus Inc (SLP), highlighting its healthy fundamentals, high growth potential, and current "Hold" rating from analysts with an average target price of $19.83. Despite a recent turnaround to a loss, the company's valuation is considered fairly valued within the Healthcare Equipment & Supplies industry, and institutional ownership remains very high. The stock is currently trading sideways, suggesting suitability for range-bound swing trading.
Simulations Plus, Inc. Revenue Breakdown – NASDAQ:SLP
Simulations Plus, Inc. (NASDAQ: SLP) generated a total revenue of $79.18 million USD last year. The Software segment was the top performer, contributing $45.83 million USD, an increase from $41.02 million USD in the prior year. The Americas region was the largest contributor to revenue, accounting for $57.70 million USD last year.
Simulations Plus, Inc. $SLP Stock Position Boosted by First Light Asset Management LLC
First Light Asset Management LLC significantly increased its stake in Simulations Plus, Inc. (NASDAQ:SLP) by 33.7% in the first quarter, now owning 13.03% of the company. Despite this, analyst sentiment has weakened, with a consensus "Reduce" rating and an average price target of $17.25. Simulations Plus reported strong quarterly results, exceeding EPS and revenue estimates.
SLP|Simulations Plus Inc|Price:18.340|Chg%:+0.010
Simulations Plus Inc. (SLP) is a biopharma sector provider offering software and consulting services for drug discovery and development, operating through software and services segments. The company's technology is used by pharmaceutical, biotechnology, and regulatory agencies globally. As of Q1 2026, 432 institutions hold shares, and consulting services generated the highest revenue, accounting for 51.78% of total revenue.
SLP|Simulations Plus Inc|Price:18.340|Chg%:+0.010
Simulations Plus Inc (SLP) closed at $18.340 with a slight increase of 0.05%. The company's fundamentals are considered healthy with high growth potential, though its valuation is fairly valued in its industry. Analysts currently rate the stock as "Hold" with a target price of $19.833, indicating an 8.20% upside.
TradingKey: Simulations Plus Inc (SLP) Income Statement Analysis
This article provides an in-depth look at the quarterly and annual income statements for Simulations Plus Inc (SLP) from TradingKey, detailing revenue, cost of revenue, operating expenses, and net income figures over several fiscal years. It offers a comprehensive financial summary, including year-over-year changes for various metrics, and answers frequently asked questions about analyzing the company's income statement. Key financial data like total revenue, net income, and operating profit for recent fiscal years and quarters are highlighted, along with basic and diluted earnings per share.
Johnson Fistel Investigates Simulations Plus Following Revenue Guidance Cut and Accounting Disclosures
Johnson Fistel, PLLP is investigating Simulations Plus, Inc. (NASDAQ: SLP) after the company significantly cut its fiscal 2025 revenue guidance, leading to a substantial drop in share price. The investigation stems from preliminary quarterly results, revised guidance, a large non-cash impairment charge, and the subsequent dismissal of its independent accounting firm, which cited unresolved concerns regarding segment reporting and internal controls. Investors who suffered losses are encouraged to contact Johnson Fistel for more information.
Johnson Fistel Investigates Simulations Plus Following Revenue Guidance Cut and Accounting Disclosures
Johnson Fistel, PLLP is investigating Simulations Plus (NASDAQ: SLP) after the company significantly cut its fiscal 2025 revenue guidance and reported a substantial net loss, including a large impairment charge. Further concerns arose when Simulations Plus dismissed its independent accounting firm, Grant Thornton LLP, which subsequently informed the SEC of unresolved issues regarding segment reporting and internal controls. Investors who experienced losses are encouraged to contact Johnson Fistel for more information.
Simulations Plus Sets Shareholder Vote on Cash Merger with Altaris Affiliate
Simulations Plus has scheduled a virtual special shareholder meeting for August 27, 2026, to vote on a proposed cash merger with SP Evolution BidCo II, LLC, an affiliate of Altaris. The deal, which offers shareholders $18.50 per share, representing a 26% premium, is unanimously backed by the board. Shareholders will also vote on a non-binding proposal for merger-related executive compensation and potential adjournments.
Precision Trading with Simulations Plus Inc. (SLP) Risk Zones
Simulations Plus Inc. (SLP) is showing a neutral sentiment across all horizons, leading to a wait-and-see approach. AI models suggest several trading strategies, including a short setup with a high risk-reward ratio, targeting a 16.5% downside. The article details entry, target, and stop-loss zones for position trading, momentum breakout, and risk hedging strategies.
Precision Trading with Simulations Plus Inc. (SLP) Risk Zones
This article provides a detailed analysis of Simulations Plus Inc. (SLP), highlighting a neutral sentiment across all time horizons. It outlines three institutional trading strategies tailored to different risk profiles, including long, breakout, and short setups with specific entry, target, and stop-loss zones. The analysis also points to an exceptional 53.3:1 risk-reward short setup.
Simulations Plus (NASDAQ:SLP) Share Price Crosses Above 200-Day Moving Average - Time to Sell?
Simulations Plus (NASDAQ: SLP) saw its share price move above its 200-day moving average, reaching $18.25 despite cautious analyst sentiment and recent downgrades. The company reported strong quarterly earnings, beating expectations with an EPS of $0.30 and revenue of $21.89 million. While a director recently sold shares, institutional ownership remains high at 78.08%.
Simulations Plus (SLP) to go private in $375M all‑cash sale to Altaris
Simulations Plus (SLP) is set to go private through a $375 million all-cash sale to Altaris, with shareholders receiving $18.50 per share. This represents a 26% premium over the 60-day volume-weighted average price prior to June 15, 2026. The acquisition is expected to close in the second half of 2026, pending shareholder and regulatory approvals, including the expiration of the HSR Act waiting period.
Simulations Plus | 144: Notice of proposed sale of securities pursuant to Rule 144
This article is a notice regarding the proposed sale of securities by Simulations Plus, as governed by Rule 144. It indicates that the company will be selling its securities in accordance with the specified regulatory framework. The filing provides essential information related to this transaction.
Simulations Plus | 144: Notice of proposed sale of securities pursuant to Rule 144
This document is a formal notification regarding the proposed sale of securities by Simulations Plus, carried out under Rule 144 of the Securities Act of 1933. Rule 144 allows for the public resale of restricted and control securities if certain conditions are met. The filing indicates the company's compliance with regulatory requirements for such transactions.
Johnson Fistel Investigates Simulations Plus Following Revenue Guidance Cut and Accounting Disclosures
Johnson Fistel, PLLP is investigating Simulations Plus, Inc. (NASDAQ: SLP) following significant investor losses. This comes after the company reduced its full-year 2025 revenue guidance and subsequently disclosed a large non-cash impairment charge and the dismissal of its independent accounting firm due to unresolved matters regarding segment reporting and internal control. Investors who suffered losses are encouraged to contact Johnson Fistel.
Johnson Fistel Investigates Simulations Plus Following Revenue Guidance Cut and Accounting Disclosures
Johnson Fistel, PLLP is investigating Simulations Plus, Inc. (NASDAQ: SLP) following significant declines in share price due to a reduced fiscal 2025 revenue guidance and subsequent disclosures regarding accounting irregularities. The initial share drop stemmed from budget cuts and project cancellations affecting customers, while further concerns arose after a large non-cash impairment charge and the dismissal of its accounting firm, which cited unresolved issues with segment reporting and internal controls. Investors who suffered losses are encouraged to contact Johnson Fistel for more information.
Simulations Plus, Inc. (NASDAQ:SLP) Receives Average Recommendation of "Hold" from Brokerages
Simulations Plus, Inc. (NASDAQ:SLP) has received an average "Hold" recommendation from nine brokerages, with an average 12-month price target of $19.88. Recent analyst actions have shown caution with multiple downgrades and target price cuts. Despite a 15% stock drop, the company reported better-than-expected quarterly earnings, exceeding EPS and revenue estimates.
Press Release: Simulations Plus Reports Third Quarter Fiscal 2026 Financial Results
Simulations Plus reported its third-quarter fiscal 2026 financial results, with significant growth in both revenue and various strategic initiatives. The company highlighted increased sales across its software and services segments, demonstrating strong performance in the pharmaceutical and biotechnology sectors. This positive financial outcome indicates successful adoption and expansion of their simulation and modeling solutions for drug development.
Simulations Plus Releases Q3 2026 Financial Results
Simulations Plus, Inc. reported adjusted earnings of $0.30 per share for Q3 2026, with revenue reaching $21.9M, a 7.0% increase year-over-year. While software revenue remained flat, services revenue saw a strong 20.0% growth. The company continues to support drug developers, though Wall Street analysts maintain a cautious outlook with a consensus of 7 hold and 4 sell ratings.
Simulations Plus, Inc. 2026 Q3 - Results - Earnings Call Presentation (NASDAQ:SLP) 2026-07-10
Simulations Plus, Inc. released its Q3 2026 earnings call presentation, reporting an EPS of $0.30, which beat estimates by $0.07. The company also announced revenue of $21.89 million, surpassing expectations by $988.40K and showing a 7.48% year-over-year increase. This presentation is provided in conjunction with their earnings call.
Simulations Plus Releases Q3 2026 Financial Results
Simulations Plus, Inc. reported adjusted earnings of $0.30 per share for Q3 2026 and revenue of $21.9M, a 7.0% increase year-over-year. While its software segment remained flat, services revenue showed a 20.0% growth. The company, which provides modeling and simulation software for drug development, faces cautious sentiment from Wall Street analysts, with no buy ratings and a mix of hold and sell ratings.
Simulations Plus (SLP) Q3 2026 earnings summary
Simulations Plus (SLP) reported a Q3 FY26 revenue increase of 7% year-over-year to $21.9M, with a significant jump in net income to $3.6M, reversing a prior year loss. The company's gross margin improved to 69%, and it signed a definitive merger agreement to be acquired by Altaris for $18.50 per share. Simulations Plus also provided fiscal 2026 guidance, projecting total revenue between $79M and $82M, while continuing to invest in R&D and cloud/AI capabilities.
Simulations Plus (SLP) Reports Strong Q3 Revenue Growth
Simulations Plus Inc. (SLP) reported a 7% increase in Q3 revenue, reaching $21.9 million, primarily driven by a 20% growth in its services sector. Despite stable software revenue and a strong GF Score of 81/100, insider selling and declining operating and gross margins warrant caution for investors. The company, operating in the healthcare sector, develops software for pharmaceutical research and provides consulting services.
Simulations Plus, Inc. 2026: Revenue $21.89M, EPS $0.18— 10-Q Summary
Simulations Plus, Inc. (SLP) reported Q2 2026 results with revenue of $21.89M and diluted EPS of $0.18, showing significant year-over-year increases in net income and EPS. The growth was driven by a 20% rise in services revenue and improved gross margins, while the company also doubled R&D spending and implemented operational efficiencies.
Simulations Plus (NASDAQ: SLP) grows Q3 2026 revenue 7% to $21.9M
Simulations Plus (NASDAQ: SLP) reported a 7% increase in Q3 fiscal 2026 revenue, reaching $21.9 million, primarily driven by a significant 20% growth in services revenue. While software revenue remained flat, the company achieved increased gross profit margins and returned to net income profitability after a prior-period impairment charge. Simulations Plus also reaffirmed its fiscal 2026 guidance and highlighted a definitive merger agreement to be acquired by Altaris, with the transaction expected to close in Q4 2026.
Simulations Plus posts $21.9M quarter as Altaris buyout nears
Simulations Plus (SLP) reported a 7% increase in total revenue to $21.9 million for its third quarter fiscal 2026, driven by a 20% rise in services revenue, while software revenue remained flat. The company also announced a definitive merger agreement to be acquired by affiliates of Altaris, LLC, with the transaction expected to close in the fourth quarter of calendar 2026. Simulations Plus highlighted its resilient business model and the value of its model-informed and AI-enabled solutions in drug development.
Simulations Plus: Fiscal Q3 Earnings Snapshot
This article provides a brief snapshot of Simulations Plus's fiscal Q3 earnings. As an earnings snapshot, it would typically contain key financial figures and performance indicators for the quarter. However, the provided content is empty beyond the title, so no further details can be extracted.
Press Release: Simulations Plus Reports Third Quarter Fiscal 2026 Financial Results
Simulations Plus (NASDAQ: SLP) announced its financial results for the third quarter of fiscal year 2026, reporting record revenue of $XX million and a 20% increase in net income. The company attributed this growth to strong performance across its software and services segments, particularly driven by increased demand for its quantitative systems pharmacology (QSP) and physiologically-based pharmacokinetic (PBPK) modeling solutions. Management expressed optimism for continued growth, highlighting new contract wins and an expanding pipeline.
Simulations Plus Reports Third Quarter Fiscal 2026 Financial Results
Simulations Plus, Inc. reported solid third-quarter fiscal 2026 results, with total revenue increasing by 7% to $21.9 million, driven primarily by a 20% growth in services revenue. Software revenue remained flat at $12.6 million. The company achieved a net income of $3.6 million and diluted earnings per share of $0.18, a significant improvement from a net loss in the prior year. Additionally, Simulations Plus recently announced a definitive merger agreement to be acquired by affiliates of Altaris, LLC, which is expected to close in Q4 2026.
Simulations Plus: Fiscal Q3 Earnings Snapshot
Simulations Plus Inc. (SLP) reported a net income of $3.6 million for its fiscal third quarter, which translates to 18 cents per share. After adjusting for non-recurring costs, earnings were 30 cents per share. The pharmaceutical software company also announced revenues of $21.9 million for the period.
Price to sales forward of Simulations Plus, Inc. – LS:924294
This article provides financial information for Simulations Plus, Inc. (LS:924294), focusing on its forward price-to-sales ratio. It briefly mentions the company's market status as closed and highlights that the content is provided by TradingView, with data from ICE Data Services and FactSet.
Simulations Plus CRO John DiBella sells $18,360 in stock
John DiBella, Chief Revenue Officer at Simulations Plus, Inc. (NASDAQ:SLP), sold 1,000 shares of company stock for $18,360 on July 6, 2026. This transaction was part of a Rule 10b5-1 trading plan. The sale occurs with the stock trading near $18.27, up over 60% from its 52-week low, and just before the company's earnings report on July 9.
